The global hemato oncology testing market size was USD 2.98 Billion in 2022 and is expected to register a steady revenue CAGR of 14.3% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of hematologic cancer, such as lymphoma, myeloma, and leukemia, around the world, rapid implementation of advanced molecular diagnostic techniques for early...